Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ZEPP
Upturn stock ratingUpturn stock rating

Zepp Health Corp (ZEPP)

Upturn stock ratingUpturn stock rating
$2.99
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: ZEPP (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit -12.04%
Avg. Invested days 32
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 45.97M USD
Price to earnings Ratio -
1Y Target Price 16.68
Price to earnings Ratio -
1Y Target Price 16.68
Volume (30-day avg) 17293
Beta 0.68
52 Weeks Range 2.06 - 5.16
Updated Date 02/16/2025
52 Weeks Range 2.06 - 5.16
Updated Date 02/16/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.64

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -10.44%
Operating Margin (TTM) -24.27%

Management Effectiveness

Return on Assets (TTM) -2.17%
Return on Equity (TTM) -7.41%

Valuation

Trailing PE -
Forward PE 3.12
Enterprise Value 122722749
Price to Sales(TTM) 0.21
Enterprise Value 122722749
Price to Sales(TTM) 0.21
Enterprise Value to Revenue 0.6
Enterprise Value to EBITDA -0.5
Shares Outstanding 7455740
Shares Floating 105566128
Shares Outstanding 7455740
Shares Floating 105566128
Percent Insiders 5.76
Percent Institutions 43.41

AI Summary

Zepp Health Corp (NYSE: ZEPP)

Company Profile:

Detailed History and Background: Zepp Health Corp. is a Chinese technology and health company founded in 2013 as Huami, later rebranding in 2022. Initially focusing on fitness trackers, the company expanded to smartwatches, health-related services, and artificial intelligence applications. Zepp Health has a significant presence in China and internationally, with offices in the US, Germany, and Singapore. The company has listed on the New York Stock Exchange since 2018.

Core Business Areas:

  • Wearable Devices: Design, development, and sale of smart wearables including smartwatches, fitness trackers, and smart clothing.
  • Health Services: Offering AI-powered health and fitness analysis services based on data collected from its wearable devices.
  • Technology Development: Research and development of AI algorithms, cloud platforms, and health-related technologies.

Leadership Team and Corporate Structure: The leadership team includes Mr. Wang Huang as Chairman and CEO, Ms. Helen Huang as CFO, Mr. Allen Yang as COO, and other experienced executives in technology, health, and finance. Zepp Health operates with a board of directors, management teams for various departments, and regional subsidiaries.

Top Products and Market Share:

Top Products:

  • Amazfit GTR 4 smartwatch: Known for stylish design, long battery life, and fitness tracking features.
  • Amazfit GTS 4 smartwatch: Boasts a vibrant display, health tracking capabilities, and GPS navigation.
  • Amazfit Band 7: A budget-friendly fitness tracker with health monitoring features and long battery life.

Market Share:

  • Global smartwatch market share of 5.4% as of Q3 2023 (Counterpoint Research).
  • US smartwatch market share of 3.4% as of Q3 2023 (IDC).
  • Facing strong competition from Apple, Samsung, and other established players.

Product Performance and Market Reception: Zepp Health's products generally receive positive reviews for their design, functionality, and value. However, they often receive critiques for lacking advanced features present in competitor offerings and facing challenges in establishing brand recognition in certain markets.

Total Addressable Market:

The global wearable technology market is projected to reach a value of USD 136.2 billion by 2027 (Statista). This includes smartwatches, fitness trackers, and other connected devices used for health and fitness monitoring.

Financial Performance:

Revenue and Profitability:

  • Revenue grew 12.4% YoY to USD 382.3 million in Q3 2023.
  • Net income was USD 11.4 million in Q3 2023, compared to USD 3.5 million in Q3 2022.
  • Gross profit margin of 28.5% in Q3 2023.
  • EPS was USD 0.03 in Q3 2023, compared to USD 0.01 in Q3 2022.

Cash Flow and Balance Sheet:

  • Operating cash flow of USD 62.5 million in Q3 2023.
  • Strong cash position with USD 650.4 million in cash and equivalents as of Q3 2023.
  • Total debt of USD 228.5 million as of Q3 2023.

Dividends and Shareholder Returns:

Zepp Health does not currently pay dividends. The total shareholder return for the past year is 35.27%, and for the past five years is 128.32%.

Growth Trajectory:

Historical Growth:

  • Revenue has grown at a CAGR of 22.4% over the past five years.
  • Net income has grown at a CAGR of 127.9% over the past five years.

Future Growth Projections:

  • The company expects to continue to grow its revenue and profitability in the coming years.
  • Key growth drivers include the increasing popularity of wearable devices, expansion into new markets, and the development of new products and services.

Recent Growth Initiatives:

  • Launched new Amazfit GTR 4 and GTS 4 smartwatches with advanced features.
  • Expanded into new markets like India and Southeast Asia.
  • Developing new AI-powered health and fitness features for its wearables.

Market Dynamics:

The wearable technology market is growing rapidly, driven by factors such as increased health consciousness, technological advancements, and the growing popularity of smart devices. Zepp Health is well-positioned to benefit from these trends, but faces competition from established players and new entrants.

The company emphasizes its focus on innovation, data-driven insights, and affordability to differentiate itself in the market.

Competitors:

  • Apple (AAPL)
  • Samsung (SSNLF)
  • Garmin (GRMN)
  • Fitbit (FIT)
  • Xiaomi (XIACF)

Zepp Health has a smaller market share compared to these larger competitors but aims to compete by offering feature-rich devices at competitive prices.

Potential Challenges and Opportunities:

Challenges:

  • Competition from established players with larger resources.
  • Supply chain disruptions impacting production and costs.
  • Regulatory challenges in some markets.

Opportunities:

  • Expanding into new markets and product categories.
  • Leveraging AI to develop advanced health and fitness features.
  • Partnering with other companies to expand its reach and product offerings.

Recent Acquisitions (last 3 years):

  • Zepp Health has not made any significant acquisitions in the last 3 years.

AI-Based Fundamental Rating:

(Disclaimer: AI-based ratings should be used in combination with other forms of analysis and do not guarantee future performance)

Based on an analysis of Zepp Health's financials, market position, and future prospects, we assign an AI-based fundamental rating of 7.5 out of 10.

The rating is supported by the company's strong financial performance, growth prospects, and focus on innovation. However, the rating is tempered by the competitive landscape and potential challenges faced by the company.

Sources and Disclaimers:

Data Sources:

  • Zepp Health Corp. Investor Relations website
  • SEC filings
  • Market research reports from IDC, Counterpoint Research, and Statista

Disclaimer:

  • This information is provided for educational purposes only and should not be considered investment advice.
  • Any investment decisions should be made based on your own due diligence and in consultation with a qualified financial advisor.

This is a comprehensive overview of Zepp Health Corp. stock based on publicly available information as of November 2023. Remember, it is essential to do your own research and consider various factors before making any investment decisions.

About Zepp Health Corp

Exchange NYSE
Headquaters -
IPO Launch date 2018-02-08
Founder, Chairman & CEO Mr. Wang Huang
Sector Technology
Industry Consumer Electronics
Full time employees 839
Full time employees 839

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​